Navigation Links
Champions Biotechnology Reports Fiscal 2009 Full-Year Financial Results
Date:8/27/2009

g statements. One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors. See Champions Biotechnology's Form 10-K for the fiscal year ended April 30, 2009 for a discussion of such risks, uncertainties and other factors. Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Biotechnology's future results, levels of activity, performance or achievements may not meet these expectations. The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Biotechnology's expectations, except as required by law.

www.championsbiotechnology.com

www.personalizedcancertreatment.com/


'/>"/>
SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
2. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
3. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
4. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
5. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
6. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
7. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
8. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
9. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
10. Malaysian Biotechnology Sector
11. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 29,000 jo...to show consistent growth during the U.S. recessio... in trouble, and health systems are coming closer ...ad of just administrators. , ...yment continued growing in October despite the she...
(Date:11/24/2009)...alif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc....developingandcommercializingnovelpainmanagementthe...ndChiefExecutiveOfficer,isscheduledtopresentatthe2...December1-2,2009atTheNewYorkPalaceHotelinNewYork,N...inancialOfficer,willbeavailabletorespondtoquestion...
(Date:11/24/2009)... The FBI recently approved the Promega Powe...pating in or generating DNA records for the Nation...dison, WI USA (PRWEB) -- The FBI recently approved... by laboratories participating in, or generating D...S). NDIS currently contains more than seven millio...
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,N...company,today,announcedthatithassubmittedaMAAtothe...mpany,senzymereplacementtherapyindevelopment,forth...eting,applicationforvelaglucerasealfathathasbeensu...ndCanada. , Basedonaglobalsupplyshortageofthe...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...Hospital Foundation,the parent company of The Chil...arma announced today that the Foundation has sold ... of RotaTeq(R) from and after October,1, 2007, to ... http://www.newscom.com/cgi-bin/prnh/20061026/RPLO...Teq(R), we further our,strategy of building a high...
... Healthcare Provider about Ways to Help ...pril 25 One4One, a unique program focused on,empo...t against cervical,cancer, starts today during Nat...s women to talk to their healthcare provider about...al cancer, while also raising money,to increase ce...
...rgizes National Medical Laboratory ... April 24 In conjunction with,National Medical La...ay,announced the winners of the Labs Are Vital(TM)...and recruit young people to the clinical,laborator...hip contest,proved successful, reaching 2.9 millio...
Other Biology Technology:Royalty Pharma Acquires Royalty Interest in RotaTeq(R) from The Children's Hospital Foundation for $182 Million 2Royalty Pharma Acquires Royalty Interest in RotaTeq(R) from The Children's Hospital Foundation for $182 Million 3One4One Campaign to Raise $1 Million to Improve Cervical Cancer Education and Resources 2One4One Campaign to Raise $1 Million to Improve Cervical Cancer Education and Resources 3One4One Campaign to Raise $1 Million to Improve Cervical Cancer Education and Resources 4Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners 2Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners 3Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners 4Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners 5
(Date:11/23/2009)...o new studies reveal in unprecedented detail how t...mble new proteins and guide them toward their dest...cular dynamics flexible fitting (MDFF) to examine ... molecular partners. , The first study, in Pro...cerns the intimate signaling between the ribosome ...
(Date:11/23/2009)...string of recent discoveries about the multiple he... this multi-purpose nutrient, increased awareness ... it, spurred research and even led to an appreciat...ranging from the health of your immune system to p...to influenza, vitamin D is now seen as one of the ...
(Date:11/23/2009)... , , , , , , , ... AUDIO: , Dr Andrew Marshall, from the Enviro...ses the discovery of Kinyongia magomberae and hi...ck here for more information. , , , ..., , , , , , , , A new spe...
Breaking Biology News(10 mins):Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Fifteenth US Patent Issued for aTyr Pharma Novel Biotherapeutic 56522 1Fifteenth US Patent Issued for aTyr Pharma Novel Biotherapeutic 56522 22009 India Excellence in Healthcare Awards 56519 12009 India Excellence in Healthcare Awards 56519 22009 India Excellence in Healthcare Awards 56519 32009 India Excellence in Healthcare Awards 56519 4Clinical Therapeutics Announces the Addition of Michael G Spigarelli MD PhD as Editor for a Refocused Pediatric Adolescent 26 Maternal Therapeu 13922 1Clinical Therapeutics Announces the Addition of Michael G Spigarelli MD PhD as Editor for a Refocused Pediatric Adolescent 26 Maternal Therapeu 13922 2
...therapy agent, researchers at UCLA,s Jonsson Cance...atory Medicine found a way to move an important bi...oose from one location in a cell ?where it could n...get area. , The discovery, outlined in the cover ...rnal Molecular Cancer Therapeutics, could have imp...
...niversity of Toronto have mapped the molecular det...stein-Barr virus immortalizes cells and causes the...e to certain types of cancer. , "Epstein-Barr viru... the world and is strongly linked to certain b-cel...pithelial cell cancer, nasopharyngeal carcinoma. E...
...d at directly controlling the expression of genes ...ead to drugs for the treatment or cure of many dis...Center. , "Virtually every disease starts at the l...r bacterial gene expression," said Dr. David Corey...s is an approach that could theoretically produce ...
Other Biology News:UCLA cancer researchers shake loose hidden biomarker 2U of T researchers map role of Epstein-Barr virus in cancer 2Gene silencing technique offers new strategy for treating, curing disease 2
...ificantly increase the shelf life of diluted perox... room temperature storage conditions in addition t...45 micron filtration, and contains no mercury or a...levels of activity for both the enzyme and the ant...
...nd affordable alternative for diagnostic assays an...sable manifold, the StatMatic I provides continuou...es. The eight-port manifold, designed for 96-well ...0, 250, or 300mL with well-to-well accuracy of 5% ...
REC PROTEIN A from Invitrogen
...ngth adhesive system which facilitates the easy re...ther side of the frame are of differing strengths;...elease adhesive whereas the reverse, which sticks ...s that when the coverslip is removed, due to the d...
Biology Products: